ATS GUIDELINES Bundle

Organ Donation Pocket Guide (ATS)

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/555200

Contents of this Issue

Navigation

Page 1 of 3

Key Points Key Points Î More than 21,000 deceased donor transplants are performed in the United States each year. Î Based on 2011 data from the Organ Procurement Transplantation Network, 26% of listed solid organ transplant candidates were too sick to be transplanted or died while awaiting transplant. Î The supply of 'traditional' donors after neurological determination of death is insufficient to provide organs to all patients who might benefit from transplants. Î Donation after circulatory determination of death (DCDD) has the potential to increase the number of deceased donor transplants by roughly 10%. Î This statement is designed to provide a framework to guide ethics and health policy considerations in adult and pediatric controlled DCDD from the perspective of critical care medicine clinicians, transplant subspecialists, and allocation authorities. Î This report addresses controlled DCDD. It does not address uncontrolled DCDD, which refers to donation after an unexpected circulatory arrest. Consent Î When patients themselves have consented to organ donation, hospital critical care and organ procurement organization (OPO) representatives should respect the patient's donation decision and provide this information to surrogate decision makers. Î After clinicians lead discussions with patients or surrogates about the decisions to withdraw life-sustaining therapies, discussions about DCDD should proceed promptly and be coordinated by professionals with the necessary skills to lead such conversations. Î Consent for DCDD should be obtained by individuals with appropriate experience and training. These individuals' organizational affiliations should always be disclosed clearly. Process

Articles in this issue

view archives of ATS GUIDELINES Bundle - Organ Donation Pocket Guide (ATS)